Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in

  News Archive

Study Removes Cancer Doubt for Multiple Sclerosis Drug
Tuesday, October 06, 2015
Researchers from Queen Mary University of London are calling on the medical community to reconsider developing a known drug to treat people with relapsing Multiple sclerosis after new evidence shows it does not increase the risk of cancer as previously thought.

Biscayne Pharmaceuticals Merges with Insero Health
Tuesday, October 06, 2015
Insero scientific co-founder and Harvard epilepsy expert Dr. Steven Schachter joins Biscayne as senior science advisor.

New Hope for Personalized Treatment of Eczema
Monday, October 05, 2015
Pharmaceutical researchers at Oregon State University have developed a new approach to treat eczema and other inflammatory skin disorders that would use individual tests and advanced science to create personalized treatments based on each person's lipid deficiencies.

FDA Accepts Sandoz Regulatory Submission For Etanercept
Monday, October 05, 2015
Etanercept is an anti-TNF medicine used to treat a range of immunological diseases including rheumatoid arthritis and psoriasis.

Inroads Against Leukaemia
Thursday, October 01, 2015
Potential for halting disease in molecule isolated from sea sponges.

Researchers Disguise Drugs As Platelets to Target Cancer
Thursday, October 01, 2015
Researchers have for the first time developed a technique that coats anticancer drugs in membranes made from a patient’s own platelets.

HIV Patients Should Be Included in Early Clinical Trials of Anti-TB Drugs
Thursday, October 01, 2015
Tuberculosis is the number one cause of death in HIV-infected patients in Africa and a leading cause of death in this population worldwide.

Novasep Strengthens its Advisory Board
Tuesday, September 29, 2015
Professors Alois Fürstner and Alois Jungbauer, renowned experts in catalysis and purification processes, will help boost innovation at Novasep

Novartis Launches 'Novartis Access'
Friday, September 25, 2015
Novartis portfolio to be offered to governments and non-governmental organizations in low- and low-middle-income countries for USD 1 per treatment, per month.

<< 1 2 3 4 5 6 7 >>
Showing Results 21 - 30 of 4159
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos